FDA Approved: RALOXIFENE HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for raloxifene hydrochloride submitted by ScieGen Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Postmenopausal Osteoporosis

Drugs mentioned

• RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

SUPPL AP for RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)